147 related articles for article (PubMed ID: 17679481)
1. [Intrathecal chemotherapy treatment of neoplastic meningitis from solid tumors using liposomal cytarabine: experience at the Istituto Regina Elena di Roma].
Pace A
Tumori; 2007; 93(3):suppl 9-12. PubMed ID: 17679481
[No Abstract] [Full Text] [Related]
2. [Experience with the intrathecal use of liposomal cytarabine at the Besta Institute].
Silvani A
Tumori; 2007; 93(3):suppl 6-8. PubMed ID: 17679480
[No Abstract] [Full Text] [Related]
3. [Efficacy of liposomal cytarabine in neoplastic meningitis].
Rudà R; Leoncini B; Laguzzi E; Trevisan E; Guarneri D; Bertetto O; Soffietti R
Tumori; 2007; 93(3):suppl 4-5. PubMed ID: 17679479
[No Abstract] [Full Text] [Related]
4. [Rationale for the use of liposomal cytarabine in meningeal carcinomatosis].
Boiardi A
Tumori; 2007; 93(3):suppl 1-3. PubMed ID: 17679478
[No Abstract] [Full Text] [Related]
5. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
Glantz MJ; Jaeckle KA; Chamberlain MC; Phuphanich S; Recht L; Swinnen LJ; Maria B; LaFollette S; Schumann GB; Cole BF; Howell SB
Clin Cancer Res; 1999 Nov; 5(11):3394-402. PubMed ID: 10589750
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Liposomal Cytarabine in the Treatment of Neoplastic Meningitis.
Jahn F; Jordan K; Behlendorf T; Globig C; Schmoll HJ; Müller-Tidow C; Jordan B
Oncology; 2015; 89(3):137-42. PubMed ID: 25791073
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience using intrathecal liposomal cytarabine to manage neoplastic meningitis in three patients with acute promyelocytic leukemia.
Duarte RF; Arnan M; Sánchez-Ortega I; de Llano MP; Abellán PF
Leuk Res; 2011 Jul; 35(7):e128-30. PubMed ID: 21501870
[No Abstract] [Full Text] [Related]
8. Intrathecal depot cytarabine therapy: a welcome addition to a limited armamentarium.
Bleyer WA
Clin Cancer Res; 1999 Nov; 5(11):3349-51. PubMed ID: 10589743
[No Abstract] [Full Text] [Related]
9. Neoplastic meningitis from breast carcinoma with complete response to liposomal cytarabine: case report.
Gaviani P; Silvani A; Corsini E; Erbetta A; Salmaggi A
Neurol Sci; 2009 Jun; 30(3):251-4. PubMed ID: 19259616
[TBL] [Abstract][Full Text] [Related]
10. Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study.
Scott BJ; van Vugt VA; Rush T; Brown T; Chen CC; Carter BS; Schwab R; Fanta P; Helsten T; Bazhenova L; Parker B; Pingle S; Saria MG; Brown BD; Piccioni DE; Kesari S
J Neurooncol; 2014 Sep; 119(2):361-8. PubMed ID: 24942463
[TBL] [Abstract][Full Text] [Related]
11. Liposomal cytarabine (DepoCyte) for the treatment of neoplastic meningitis.
Rueda Domínguez A; Olmos Hidalgo D; Viciana Garrido R; Torres Sánchez E
Clin Transl Oncol; 2005 Jul; 7(6):232-8. PubMed ID: 16131445
[TBL] [Abstract][Full Text] [Related]
12. Liposomal cytarabine: new drug. Lymphomatous meningitis: no better than standard cytarabine.
Prescrire Int; 2006 Feb; 15(81):11-2. PubMed ID: 16548098
[TBL] [Abstract][Full Text] [Related]
13. Treatment of lymphomatous and leukemic meningitis with liposomal encapsulated cytarabine.
Kripp M; Hofheinz RD
Int J Nanomedicine; 2008; 3(4):397-401. PubMed ID: 19337408
[TBL] [Abstract][Full Text] [Related]
14. Management of leptomeningeal malignancy.
Pentheroudakis G; Pavlidis N
Expert Opin Pharmacother; 2005 Jun; 6(7):1115-25. PubMed ID: 15957966
[TBL] [Abstract][Full Text] [Related]
15. Liposomal cytarabine in neoplastic meningitis from primary brain tumors: a single institutional experience.
Gaviani P; Corsini E; Salmaggi A; Lamperti E; Botturi A; Erbetta A; Milanesi I; Legnani F; Pollo B; Silvani A
Neurol Sci; 2013 Dec; 34(12):2151-7. PubMed ID: 23525755
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
Niwińska A; Rudnicka H; Murawska M
Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis: efficacy and long-term safety in a single institution.
Brion A; Legrand F; Larosa F; Schillinger F; Garnache-Ottou F; Helias P; Fontan J; Heczko M; Delaby P; Daguindau E; Vuillier J; Chauchet A; Deconinck E
Invest New Drugs; 2012 Aug; 30(4):1697-702. PubMed ID: 21229289
[TBL] [Abstract][Full Text] [Related]
18. Current treatment approaches for neoplastic meningitis: nursing management of patients receiving intrathecal DepoCyt.
Craig C
Oncol Nurs Forum; 2000 Sep; 27(8):1225-30; quiz 1231-2. PubMed ID: 11013903
[TBL] [Abstract][Full Text] [Related]
19. Neurological complications after intrathecal liposomal cytarabine application in patients after allogeneic haematopoietic stem cell transplantation.
Hilgendorf I; Wolff D; Junghanss C; Kahl C; Leithaeuser M; Steiner B; Casper J; Freund M
Ann Hematol; 2008 Dec; 87(12):1009-12. PubMed ID: 18704421
[TBL] [Abstract][Full Text] [Related]
20. Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer.
Mrugala MM; Kim B; Sharma A; Johnson N; Graham C; Kurland BF; Gralow J
Clin Breast Cancer; 2019 Oct; 19(5):311-316. PubMed ID: 31175053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]